141 related articles for article (PubMed ID: 36343044)
1. Safety and efficacy of MT10107 in post-stroke upper limb spasticity treatment: A phase I randomized controlled trial.
Lee J; Chun MH; Ko YJ; Lee SU; Kim DY; Paik NJ
Medicine (Baltimore); 2022 Nov; 101(44):e31367. PubMed ID: 36343044
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of MT10107 (Coretox) in Poststroke Upper Limb Spasticity Treatment: A Randomized, Double-Blind, Active Drug-Controlled, Multicenter, Phase III Clinical Trial.
Lee J; Chun MH; Ko YJ; Lee SU; Kim DY; Paik NJ; Kwon BS; Park YG
Arch Phys Med Rehabil; 2020 Sep; 101(9):1485-1496. PubMed ID: 32497599
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of NABOTA in post-stroke upper limb spasticity: a phase 3 multicenter, double-blinded, randomized controlled trial.
Nam HS; Park YG; Paik NJ; Oh BM; Chun MH; Yang HE; Kim DH; Yi Y; Seo HG; Kim KD; Chang MC; Ryu JH; Lee SU
J Neurol Sci; 2015 Oct; 357(1-2):192-7. PubMed ID: 26233808
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of letibotulinumtoxinA(BOTULAX®) in treatment of post stroke upper limb spasticity: a randomized, double blind, multi-center, phase III clinical trial.
Do KH; Chun MH; Paik NJ; Park YG; Lee SU; Kim MW; Kim DK
Clin Rehabil; 2017 Sep; 31(9):1179-1188. PubMed ID: 28118733
[TBL] [Abstract][Full Text] [Related]
5. Neuronox versus BOTOX in the Treatment of Post-Stroke Upper Limb Spasticity: A Multicenter Randomized Controlled Trial.
Seo HG; Paik NJ; Lee SU; Oh BM; Chun MH; Kwon BS; Bang MS
PLoS One; 2015; 10(6):e0128633. PubMed ID: 26030192
[TBL] [Abstract][Full Text] [Related]
6. A Randomized, Double-Blind, Active Control, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Liztox
Ye DH; Chun MH; Park YG; Paik NJ; Lee SU; Yoo SD; Kim DY
Toxins (Basel); 2023 Dec; 15(12):. PubMed ID: 38133201
[TBL] [Abstract][Full Text] [Related]
7. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of OnabotulinumtoxinA 400 Units in Patients with Post-Stroke Upper Limb Spasticity: Final Report of a Randomized, Double-Blind, Placebo-Controlled Trial with an Open-Label Extension Phase.
Abo M; Shigematsu T; Hara H; Matsuda Y; Nimura A; Yamashita Y; Takahashi K
Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32085529
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type A in post-stroke upper limb spasticity.
Kaji R; Osako Y; Suyama K; Maeda T; Uechi Y; Iwasaki M;
Curr Med Res Opin; 2010 Aug; 26(8):1983-92. PubMed ID: 20569068
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.
Gracies JM; Brashear A; Jech R; McAllister P; Banach M; Valkovic P; Walker H; Marciniak C; Deltombe T; Skoromets A; Khatkova S; Edgley S; Gul F; Catus F; De Fer BB; Vilain C; Picaut P;
Lancet Neurol; 2015 Oct; 14(10):992-1001. PubMed ID: 26318836
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of AbobotulinumtoxinA (Dysport) for the Treatment of Hemiparesis in Adults With Upper Limb Spasticity Previously Treated With Botulinum Toxin: Subanalysis From a Phase 3 Randomized Controlled Trial.
Marciniak C; McAllister P; Walker H; Brashear A; Edgley S; Deltombe T; Khatkova S; Banach M; Gul F; Vilain C; Picaut P; Grandoulier AS; Gracies JM;
PM R; 2017 Dec; 9(12):1181-1190. PubMed ID: 28625615
[TBL] [Abstract][Full Text] [Related]
12. IncobotulinumtoxinA Efficacy and Safety in Adults with Upper-Limb Spasticity Following Stroke: Results from the Open-Label Extension Period of a Phase 3 Study.
Marciniak C; Munin MC; Brashear A; Rubin BS; Patel AT; Slawek J; Hanschmann A; Hiersemenzel R; Elovic EP
Adv Ther; 2019 Jan; 36(1):187-199. PubMed ID: 30484117
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of HU-014 in the Treatment of Post-Stroke Upper Limb Spasticity: A Phase I Pilot Study.
Lee J; Chun MH
Toxins (Basel); 2022 Oct; 14(11):. PubMed ID: 36355980
[TBL] [Abstract][Full Text] [Related]
14. Impact of early intervention with onabotulinumtoxinA treatment in adult patients with post-stroke lower limb spasticity: results from the double-blind, placebo-controlled, phase 3 REFLEX study.
Patel AT; Ward AB; Geis C; Jost WH; Liu C; Dimitrova R
J Neural Transm (Vienna); 2020 Dec; 127(12):1619-1629. PubMed ID: 33106968
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of incobotulinumtoxinA in post-stroke upper-limb spasticity in Japanese subjects: results from a randomized, double-blind, placebo-controlled study (J-PURE).
Masakado Y; Abo M; Kondo K; Saeki S; Saitoh E; Dekundy A; Hanschmann A; Kaji R;
J Neurol; 2020 Jul; 267(7):2029-2041. PubMed ID: 32219557
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial.
Kaji R; Osako Y; Suyama K; Maeda T; Uechi Y; Iwasaki M;
J Neurol; 2010 Aug; 257(8):1330-7. PubMed ID: 20358216
[TBL] [Abstract][Full Text] [Related]
17. Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke.
Santamato A; Panza F; Intiso D; Baricich A; Picelli A; Smania N; Fortunato F; Seripa D; Fiore P; Ranieri M
J Neurol Sci; 2017 Jul; 378():182-186. PubMed ID: 28566161
[TBL] [Abstract][Full Text] [Related]
18. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population.
Pandyan AD; Vuadens P; van Wijck FM; Stark S; Johnson GR; Barnes MP
Clin Rehabil; 2002 Sep; 16(6):654-60. PubMed ID: 12392341
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of onabotulinumtoxinA with standardized occupational therapy for treatment of pediatric upper limb spasticity: Phase III placebo-controlled randomized trial.
Dimitrova R; McCusker E; Gormley M; Fehlings D; Alter KE; Greaves S; Liu C; Brin MF
NeuroRehabilitation; 2021; 49(3):469-479. PubMed ID: 34334431
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke.
Bakheit AM; Pittock S; Moore AP; Wurker M; Otto S; Erbguth F; Coxon L
Eur J Neurol; 2001 Nov; 8(6):559-65. PubMed ID: 11784339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
